Overview

The Optimal Intervention Time of Radiotherapy for Oligometastatic Stage IV Non-small Cell Lung Cancer（NSCLC）

Status:
Recruiting
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
This study evaluates the optimal intervention time of radiotherapy for oligometastatic stage iv lung cancer.
Phase:
Phase 3
Details
Lead Sponsor:
Sichuan Cancer Hospital and Research Institute
Collaborators:
Cancer Hospital of Guizhou Province
Mianyang Central Hospital
Treatments:
Cisplatin
Docetaxel
Pemetrexed